Key points are not available for this paper at this time.
The authors' results suggest that MRgFUS CTT is a very effective treatment option for therapy-resistant ET.
Gallay et al. (Fri,) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: